BRNS Barinthus Biotherapeutics PLC

Fundamentals / CIK 0001828185 / USD

Barinthus Biotherapeutics PLC reported $0 in revenue and a net loss of $41.77M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BRNS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$51.80M$25.90M$0-$72.38MFY 2020 Revenue: $4.82MFY 2020 Net Income: -$17.71M2020FY 2021 Revenue: $268KFY 2021 Net Income: -$50.87M2021FY 2022 Revenue: $44.70MFY 2022 Net Income: $5.34M2022FY 2023 Revenue: $802KFY 2023 Net Income: -$73.35M2023FY 2024 Revenue: $14.97MFY 2024 Net Income: -$61.07M2024FY 2025 Revenue: $0FY 2025 Net Income: -$66.43M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $14.97M $802K $44.70M $268K $4.82M
Research & Development $25.56M $42.24M $44.87M $42.35M $20.37M $14.39M
Total Operating Expenses $71.06M $84.11M $84.72M $48.74M $45.49M $24.87M
Operating Income -$70.56M -$67.97M -$83.91M -$4.04M -$45.22M -$20.05M
EBITDA -$64.71M -$62.17M -$78.48M $282K -$44.62M -$19.84M
Interest Income $1.96M $2.68M $2.88M $3.10M $2.0K $0
Interest Expense $51K $53K $28K $19K $2.67M $3.60M
Income Before Tax -$66.63M -$61.23M -$76.52M $850K -$51.14M --
Income Tax Expense -$175K -$44K -$3.08M -$4.47M -$28K $95K
Net Income -$66.43M -$61.07M -$73.35M $5.34M -$50.87M -$17.71M
Basic EPS -$1.64 -$1.55 -$1.91 $0.14 -$1.96 -$2.24
Diluted EPS -$1.64 -$1.55 -$1.91 $0.14 -$1.96 -$2.24
Basic Shares Outstanding 40.5M 39.3M 38.4M 37.2M 25.9M 7.9M
Diluted Shares Outstanding 40.5M 39.3M 38.4M 38.2M 25.9M 7.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue -- -- -- $0 -- -- $0 $14.97M
Research & Development $3.92M $3.59M $3.93M $5.39M $7.95M $8.29M $8.31M $11.14M
Total Operating Expenses $11.02M $6.12M $11.57M $15.22M $23.34M $20.93M $23.57M $24.56M
Operating Income -$11.02M -$6.08M -$11.56M -$15.07M -$23.32M -$20.60M -$23.39M -$9.38M
EBITDA -$10.20M -$5.22M -$10.66M -$14.16M -$21.32M -$18.57M -$21.96M -$7.91M
Interest Income $343K $350K $406K $472K $523K $556K $637K $631K
Interest Expense $14K $13K $13K $13K $12K $13K $12K $17K
Income Before Tax -$10.62M -$5.55M -$11.16M -$14.64M -$21.15M -$19.68M -$20.59M -$8.13M
Income Tax Expense -$23K -$16K -$57K -$71K -$25K -$22K $3.0K -$3.0K
Net Income -$10.58M -$5.53M -$11.09M -$14.57M -$21.12M -$19.65M -$20.54M -$8.11M
Basic EPS -$0.26 -$0.14 -- -$0.36 -$0.52 -$0.49 -- -$0.21
Diluted EPS -$0.26 -$0.14 -- -$0.36 -$0.52 -$0.49 -- -$0.21
Basic Shares Outstanding 40.8M 40.8M -- 40.7M 40.3M 40.3M -- 39.4M
Diluted Shares Outstanding 40.8M 40.8M -- 40.7M 40.3M 40.3M -- 39.4M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $70.46M $110.7M $142.1M $194.4M $214.1M $43.27M
Cash & Short-Term Investments $70.46M $110.7M $142.1M $194.4M $214.1M $43.27M
Accounts Receivable, Net -- -- -- $323K $20K $518K
Other Current Assets $115K $344K $1.47M $611K $995K $29K
Total Current Assets $77.79M $125.7M $156.9M $213.0M $226.8M $47.90M
Property, Plant & Equipment, Net $3.52M $7.37M $11.82M $7.96M $1.83M $629K
Goodwill -- $0 $12.21M $12.21M $12.63M --
Intangible Assets $14.29M $21.95M $25.11M $28.27M $31.43M --
Total Non-Current Assets $20.38M $34.59M $57.60M $57.16M $53.95M $2.77M
Total Assets $98.17M $160.3M $214.5M $270.2M $280.7M $50.67M
Accounts Payable $350K $2.47M $1.60M $3.75M $2.42M $4.67M
Short-Term Debt -- -- -- -- $159K --
Deferred Revenue (Current) -- -- -- -- $182K $245K
Total Current Liabilities $10.02M $15.66M $12.60M $12.24M $11.16M $7.64M
Other Non-Current Liabilities $1.48M $1.36M $1.32M $965K -- --
Total Non-Current Liabilities $13.86M $14.54M $14.91M $14.76M $17.00M $46.17M
Total Liabilities $23.88M $30.19M $27.51M $27.00M $28.15M $53.81M
Total Debt (incl. Leases) $11.28M $12.01M $12.98M $8.77M $7.22M $1.66M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $0
Retained Earnings -$304.1M -$237.7M -$176.6M -$103.2M -$108.6M -$57.72M
Total Stockholders' Equity $74.21M $130.0M $186.8M $242.9M $252.1M --
Total Equity $74.29M $130.1M $187.0M $243.2M $252.6M -$36.91M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $59.30M $65.86M $70.46M $74.27M $86.26M $99.12M $110.7M --
Cash & Short-Term Investments $59.30M $65.86M $70.46M $74.27M $86.26M $99.12M $110.7M --
Other Current Assets $151K $194K $115K $663K $854K $435K $344K $464K
Total Current Assets $63.27M $72.66M $77.79M $86.78M $100.4M $109.9M $125.7M $134.7M
Property, Plant & Equipment, Net $3.04M $3.27M $3.52M $4.52M $4.51M $6.20M $7.37M $10.72M
Goodwill -- -- -- -- -- -- $0 $12.21M
Intangible Assets $13.04M $13.67M $14.29M $14.91M $20.37M $21.16M $21.95M $22.74M
Total Non-Current Assets $18.62M $19.48M $20.38M $22.42M $29.15M $32.11M $34.59M $54.03M
Total Assets $81.89M $92.14M $98.17M $109.2M $129.6M $142.0M $160.3M $188.7M
Accounts Payable $535K $993K $350K $698K $1.80M $1.36M $2.47M $3.08M
Total Current Liabilities $11.42M $12.00M $10.02M $10.80M $12.72M $11.98M $15.66M $15.07M
Other Non-Current Liabilities $1.49M $1.47M $1.48M $1.46M $1.47M $1.40M $1.36M $1.41M
Total Non-Current Liabilities $13.34M $13.66M $13.86M $13.84M $14.36M $14.43M $14.54M $14.16M
Total Liabilities $24.76M $25.66M $23.88M $24.64M $27.08M $26.40M $30.19M $29.23M
Total Debt (incl. Leases) $10.29M $11.01M $11.28M $11.57M $11.99M $11.92M $12.01M $12.67M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$320.2M -$309.6M -$304.1M -$293.0M -$278.4M -$257.3M -$237.7M -$217.1M
Total Stockholders' Equity $57.07M $66.40M $74.21M $84.47M $102.4M $115.5M $130.0M $159.3M
Total Equity $57.13M $66.48M $74.29M $84.56M $102.5M $115.6M $130.1M $159.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$66.46M -$61.18M -$73.45M $5.32M -$51.11M -$17.93M
Depreciation & Amortization $5.84M $5.80M $5.43M $4.32M $602K $208K
Stock-Based Compensation $468K $4.71M $5.05M $9.88M $16.49M $3.62M
Change in Receivables -- $0 $5.80M -$5.83M $559K $479K
Change in Payables -$2.20M $898K -$3.38M $1.14M -$3.53M $586K
Operating Cash Flow -$47.98M -$28.94M -$50.92M -$14.43M -$32.58M -$11.03M
Capital Expenditure -$37K -$892K -$5.41M -$6.14M -$1.15M -$293K
Free Cash Flow -$48.02M -$29.83M -$56.34M -$20.57M -$33.73M -$11.32M
Acquisitions, Net -- -- -- -- -$11.77M --
Investing Cash Flow $416K -$892K -$5.41M -$5.75M -$12.91M -$293K
Common Stock Issued $0 $2.16M $2.04M $484K $102.8M --
Financing Cash Flow $2.0K $2.16M $1.87M $325K $222.7M $41.44M
Net Change in Cash -$40.55M -$29.69M -$52.30M -$19.67M $170.8M $31.83M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$10.60M -$5.53M -$11.10M -$14.57M -$21.13M -$19.66M -$20.59M -$8.13M
Depreciation & Amortization $820K $856K $909K $901K $2.00M $2.03M $1.43M $1.48M
Stock-Based Compensation $433K $556K $696K -$415K -$281K $468K $755K $1.14M
Change in Payables -$451K $644K -$348K -$1.04M $342K -$1.16M -$460K $391K
Operating Cash Flow -$8.09M -$3.37M -$4.24M -$10.73M -$18.11M -$14.90M $13.09M -$18.20M
Capital Expenditure $0 $0 $0 $0 -$32K -$5.0K -$278K -$114K
Free Cash Flow -$8.09M -$3.37M -$4.24M -$10.73M -$18.14M -$14.91M $12.81M -$18.31M
Investing Cash Flow $61K $55K $2.0K $451K -$32K -$5.0K -$278K -$114K
Common Stock Issued -- -- $0 $0 $0 $0 $837K $465K
Financing Cash Flow $0 $0 $0 $0 $0 $2.0K $837K $465K
Net Change in Cash -$7.56M -$4.66M -$3.82M -$12.11M -$12.79M -$11.82M $6.30M -$11.67M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -454.1% -10463.1% -9.0% -16873.5% -415.8%
Net Profit Margin -- -408.0% -9145.5% 11.9% -18979.5% -367.3%
Return on Equity (ROE) -89.5% -47.0% -39.3% 2.2% -20.2% --
Return on Assets (ROA) -67.7% -38.1% -34.2% 2.0% -18.1% -34.9%
Current Ratio 7.77x 8.03x 12.45x 17.40x 20.32x 6.27x
Quick Ratio 7.03x 7.07x 11.28x 15.90x 19.19x 5.73x
Debt to Equity 0.15x 0.09x 0.07x 0.04x 0.03x --
Revenue Growth (YoY) -100.0% +1766.5% -98.2% +16580.2% -94.4% --
Net Income Growth (YoY) -- -- -1473.0% -- -- --
EPS Growth (YoY) -- -- -1464.3% -- -- --
5Y Revenue / Share Growth -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -- -- -- -- -- -- -454.1% -431.3%
Net Profit Margin -- -- -- -- -- -- -408.0% -386.3%
Return on Equity (ROE) -73.2% -78.8% -89.5% -89.8% -67.8% -56.5% -47.0% -36.3%
Return on Assets (ROA) -51.0% -56.8% -67.7% -69.5% -53.6% -45.9% -38.1% -30.6%
Current Ratio 5.54x 6.05x 7.77x 8.04x 7.89x 9.18x 8.03x 8.93x
Quick Ratio 5.19x 5.49x 7.03x 6.88x 6.78x 8.28x 7.07x --
Debt to Equity 0.18x 0.17x 0.15x 0.14x 0.12x 0.10x 0.09x 0.08x
Revenue Growth (YoY) -- -- -- -100.0% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -132.4% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -133.1% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001828185) · from March 31, 2020 Data through June 30, 2026 · synced Nov 21, 2026, 05:02 UTC · Open in terminal